Patent ID: 9388221
Filing Date: 2016-07-12
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A method for inducing broadly cross-neutralizing antibodies against cutaneous and mucosal papillomavirus types comprising: administering to a human in need of an immune response to cutaneous and/or mucosal papillomavirus types, an immunogenically effective dose of a composition comprising an expression vector comprising a polynucleotide encoding an immunogenic peptide or protein of at least 10 and up to 88 amino acid residues in length, said peptide or protein having a sequence corresponding to a sequence of corresponding length from the N terminal amino acids 1-88 of a papillomavirus L2 protein, wherein administration of said composition thereby induces the production of broadly cross-neutralizing antibodies against cutaneous and mucosal papillomavirus types in said human.